PFRXvsTSPAETF Comparison
Putnam Focused U.S. Research ETF (PFRX) belongs to the US Multi-Factor segment. T. Rowe Price U.S. Equity Research ETF (TSPA) is part of the US Large Cap segment. Both ETFs have the same top 3 sector exposures: Technology, Finance and Healthcare. PFRX is more expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.34% for TSPA. Run a side-by-side ETF comparison of PFRX and TSPA below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PFRX vs TSPA performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PFRX TSPA | -3.23%-4.13% | n/a-3.14% | n/a+10.44% | n/a+10.69% | n/a+76.08% | n/a+73.41% |
| Flows | PFRX TSPA | -$26M+$132M | -+$331M | -+$2.27B | -+$2.30B | -+$3.96B | -+$3.98B |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PFRX TSPA | n/a+14.70% | n/a+14.10% | n/a+15.46% | n/a+17.86% |
| Max drawdown | PFRX TSPA | n/a-6.59% | n/a-9.19% | n/a-19.15% | n/a-24.81% |
| Max drawdown duration | PFRX TSPA | n/a35d | n/a75d | n/a127d | n/a704d |
PFRX | TSPA | |
Last sale 11/13/2026 at 2:30 PM | $47.45 | |
| Previous close 11/11/2026 | $47.68 | |
| Consolidated volume 11/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
PFRX | TSPA | |
|---|---|---|
| Last price | – | $47.45 |
| 1D performance | – | -0.48% |
| AuM | $524.03 M | $4.64 B |
| E/R | 0.35% | 0.34% |
PFRX | TSPA | |
|---|---|---|
| Management strategy | Active | Active |
| Provider | Putnam | T. Rowe Price |
| Benchmark | - | - |
| N° of holdings | 45 | 329 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 28, 2026 | June 8, 2021 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
